Sanford H Barsky

Summary

Affiliation: University of California
Country: USA

Publications

  1. ncbi Histopathologic and molecular alterations in bronchial epithelium in habitual smokers of marijuana, cocaine, and/or tobacco
    S H Barsky
    Department of Pathology, University of California, Los Angeles, USA
    J Natl Cancer Inst 90:1198-205. 1998
  2. ncbi Myoepithelial mRNA expression profiling reveals a common tumor-suppressor phenotype
    Sanford H Barsky
    Department of Pathology and Revlon UCLA Breast Center, UCLA School of Medicine, Los Angeles, CA 90024, USA
    Exp Mol Pathol 74:113-22. 2003
  3. ncbi Breast carcinomatous tumoral emboli can result from encircling lymphovasculogenesis rather than lymphovascular invasion
    Sepi Mahooti
    Department of Pathology, The Ohio State University College of Medicine, Columbus, Ohio 43210, USA
    Oncotarget 1:131-47. 2010
  4. ncbi Establishment of an immortalized cell line and transplantable xenograft from a bronchioloalveolar lung carcinoma of a cat
    Deborah A Grossman
    Department of Pathology, UCLA School of Medicine, Los Angeles, CA 90024, USA
    Am J Vet Res 63:1745-53. 2002
  5. ncbi Singular v dual inhibition of SNF2L and its isoform, SNF2LT, have similar effects on DNA damage but opposite effects on the DNA damage response, cancer cell growth arrest and apoptosis
    Yin Ye
    Department of Pathology, University of Nevada School of Medicine, Reno, NV, USA
    Oncotarget 3:475-89. 2012
  6. ncbi Inhibition of expression of the chromatin remodeling gene, SNF2L, selectively leads to DNA damage, growth inhibition, and cancer cell death
    Yin Ye
    Department of Pathology, University of Nevada School of Medicine, Reno, NV 89557 0350, USA
    Mol Cancer Res 7:1984-99. 2009
  7. ncbi Early to intermediate steps of tumor embolic formation involve specific proteolytic processing of E-cadherin regulated by Rab7
    Yin Ye
    Department of Pathology, University of Nevada School of Medicine, Reno, NV 89557, USA
    Mol Cancer Res 10:713-26. 2012
  8. ncbi Myoepithelial cells: autocrine and paracrine suppressors of breast cancer progression
    Sanford H Barsky
    Department of Pathology, The Ohio State University College of Medicine, Columbus, Ohio 43210, USA
    J Mammary Gland Biol Neoplasia 10:249-60. 2005
  9. ncbi Synthetic cannabinoid receptor agonists inhibit tumor growth and metastasis of breast cancer
    Zahida Qamri
    Department of Pathology, Ohio State University Medical Center, Columbus, OH 43210, USA
    Mol Cancer Ther 8:3117-29. 2009
  10. ncbi ERalpha suppresses slug expression directly by transcriptional repression
    Yin Ye
    Department of Pathology, The Ohio State University College of Medicine, 129 Hamilton Hall, 1645 Neil Avenue, Columbus, OH 43210, USA
    Biochem J 416:179-87. 2008

Collaborators

  • Jian Xin Gao
  • Elizabeth A McNiel
  • Li Chen
  • James S Tomlinson
  • M D Roth
  • Toru Nakano
  • Helena Chang
  • Susan M Love
  • Carl Morrison
  • Hilda Chamras
  • J A Glaspy
  • Yin Ye
  • Kurtis Yearsley
  • Yi Xiao
  • Mary L Alpaugh
  • Wenting Wang
  • Rulong Shen
  • Deborah A Grossman
  • James J Liu
  • Joseph D Tellez
  • Sepi Mahooti
  • Zahida Qamri
  • Susie Jones
  • Kyle Porter
  • Aparna S Joshi
  • Robert G Parker
  • Henry C H Tsai
  • Seung-Hye Choi
  • Jerome T O'Connell
  • Canhui Liu
  • Alicia R Lange
  • Honglin Tian
  • Fredika M Robertson
  • Quintao Yan
  • Ganju K Ramesh
  • Meagan Belcher
  • Keding Hua
  • Charles L Shapiro
  • Maria Durazo
  • Gang He
  • David Jarjoura
  • Ramesh K Ganju
  • Mohd W Nasser
  • Altaf A Wani
  • Caroline E Bass
  • Anju Preet
  • Gustavo Leone
  • Brandon S Shetuni
  • Qintao Yan
  • Qien Wang
  • Qingtao Yan
  • Gauri A Gholap
  • Sedigheh Keyhani
  • Abhi S Gholap
  • Girish M Sharangpani
  • Amitabha S Basu
  • Robert Bennion
  • Sina Kasraeian
  • Timothy B Hackett
  • Perrin Beatty
  • Mai Nguyen
  • Edward Livingston
  • Alan L Hiti
  • Zhi Ming Shao
  • Cammy M Hacker
  • Liping Zhang
  • Zhi-Ming Shao
  • Timothy F Lane
  • Maryam Sartippour

Detail Information

Publications28

  1. ncbi Histopathologic and molecular alterations in bronchial epithelium in habitual smokers of marijuana, cocaine, and/or tobacco
    S H Barsky
    Department of Pathology, University of California, Los Angeles, USA
    J Natl Cancer Inst 90:1198-205. 1998
    ....
  2. ncbi Myoepithelial mRNA expression profiling reveals a common tumor-suppressor phenotype
    Sanford H Barsky
    Department of Pathology and Revlon UCLA Breast Center, UCLA School of Medicine, Los Angeles, CA 90024, USA
    Exp Mol Pathol 74:113-22. 2003
    ..Developmental genes were also differentially expressed (either over or underexpressed). These studies confirm our previous impression that human myoepithelial cells express a distinct tumor-suppressor phenotype...
  3. ncbi Breast carcinomatous tumoral emboli can result from encircling lymphovasculogenesis rather than lymphovascular invasion
    Sepi Mahooti
    Department of Pathology, The Ohio State University College of Medicine, Columbus, Ohio 43210, USA
    Oncotarget 1:131-47. 2010
    ..Collectively both experimental as well as observational studies suggested the possibility that these breast cancer emboli resulted from encircling lymphovasculogenesis rather than conventional lymphovascular invasion...
  4. ncbi Establishment of an immortalized cell line and transplantable xenograft from a bronchioloalveolar lung carcinoma of a cat
    Deborah A Grossman
    Department of Pathology, UCLA School of Medicine, Los Angeles, CA 90024, USA
    Am J Vet Res 63:1745-53. 2002
    ..CONCLUSIONS: Both the cell line and xenograft retained their autochthonous BAC phenotype, making them useful for the subsequent dissection of molecular abnormalities in feline BAC and in vitro screening of chemotherapeutic agents...
  5. ncbi Singular v dual inhibition of SNF2L and its isoform, SNF2LT, have similar effects on DNA damage but opposite effects on the DNA damage response, cancer cell growth arrest and apoptosis
    Yin Ye
    Department of Pathology, University of Nevada School of Medicine, Reno, NV, USA
    Oncotarget 3:475-89. 2012
    ..Cancer cell lines which endogenously express low levels of both SNF2L and its isoform mimic the situation of dual knockdown and permit DNA damage which is allowed to propagate unchecked...
  6. ncbi Inhibition of expression of the chromatin remodeling gene, SNF2L, selectively leads to DNA damage, growth inhibition, and cancer cell death
    Yin Ye
    Department of Pathology, University of Nevada School of Medicine, Reno, NV 89557 0350, USA
    Mol Cancer Res 7:1984-99. 2009
    ..This raised the hypothesis that cancers are sensitive to SNF2L knockdown because, unlike their normal counterparts, they lack sufficient compensation from other family members...
  7. ncbi Early to intermediate steps of tumor embolic formation involve specific proteolytic processing of E-cadherin regulated by Rab7
    Yin Ye
    Department of Pathology, University of Nevada School of Medicine, Reno, NV 89557, USA
    Mol Cancer Res 10:713-26. 2012
    ....
  8. ncbi Myoepithelial cells: autocrine and paracrine suppressors of breast cancer progression
    Sanford H Barsky
    Department of Pathology, The Ohio State University College of Medicine, Columbus, Ohio 43210, USA
    J Mammary Gland Biol Neoplasia 10:249-60. 2005
    ....
  9. ncbi Synthetic cannabinoid receptor agonists inhibit tumor growth and metastasis of breast cancer
    Zahida Qamri
    Department of Pathology, Ohio State University Medical Center, Columbus, OH 43210, USA
    Mol Cancer Ther 8:3117-29. 2009
    ..These results indicate that CB1 and CB2 receptors could be used to develop novel therapeutic strategies against breast cancer growth and metastasis...
  10. ncbi ERalpha suppresses slug expression directly by transcriptional repression
    Yin Ye
    Department of Pathology, The Ohio State University College of Medicine, 129 Hamilton Hall, 1645 Neil Avenue, Columbus, OH 43210, USA
    Biochem J 416:179-87. 2008
    ..The efficacy of the effect of ERalpha on slug repression was dependent on the overall level of ERalpha. These observations confirmed that slug was an E2-responsive gene...
  11. ncbi Piwil2 is expressed in various stages of breast cancers and has the potential to be used as a novel biomarker
    James J Liu
    Department of Pathology, Ohio State University Medical Center, Columbus, OH 43210, USA
    Int J Clin Exp Pathol 3:328-37. 2010
    ..In conclusion, piwil2 is expressed in various stages of breast cancers and has the potential to be used a novel biomarker...
  12. ncbi The lymphovascular embolus of inflammatory breast cancer expresses a stem cell-like phenotype
    Yi Xiao
    Department of Pathology, The Ohio State University College of Medicine, 129 Hamilton Hall, 1645 Neil Ave, Columbus, OH 43210 1218, USA
    Am J Pathol 173:561-74. 2008
    ..This stem cell-like phenotype may contribute to the aggressive nature of IBC but also may lend itself to selective targeting...
  13. ncbi E-cadherin accumulation within the lymphovascular embolus of inflammatory breast cancer is due to altered trafficking
    Yin Ye
    Department of Pathology, University of Nevada School of Medicine, Reno, NV 89557, USA
    Anticancer Res 30:3903-10. 2010
    ..These findings suggest that it is the altered E-cadherin trafficking that contributes to its oncogenic rather than suppressive role in IBC...
  14. ncbi Relationship of sialyl-Lewis(x/a) underexpression and E-cadherin overexpression in the lymphovascular embolus of inflammatory breast carcinoma
    Mary L Alpaugh
    Department of Pathology, University of California at Los Angeles School of Medicine, Los Angeles, California 90024, USA
    Am J Pathol 161:619-28. 2002
    ..Our findings support the cooperative relationship of sLe(x/a) underexpression and E-cadherin overexpression in the genesis of the lymphovascular embolus of IBC...
  15. ncbi Mechanisms of disease: breast tumor pathogenesis and the role of the myoepithelial cell
    Sanford H Barsky
    Department of Pathology, The Ohio State University College of Medicine, Columbus, OH 43210, USA
    Nat Clin Pract Oncol 3:138-51. 2006
    ..Studies of primary and immortalized myoepithelial cell lines indicate that these cells exhibit a natural tumor suppressor function. Functional studies show that these cells have anti-invasive and antiangiogenic phenotypes...
  16. ncbi Angiosarcoma developing in a breast after conservation treatment for breast cancer
    Robert G Parker
    Department of Radiation Oncology, UCLA Medical Center, Los Angeles, California, USA
    Am J Clin Oncol 26:486-8. 2003
  17. ncbi Reversible model of spheroid formation allows for high efficiency of gene delivery ex vivo and accurate gene assessment in vivo
    Mary L Alpaugh
    Department of Pathology, UCLA School of Medicine, Los Angeles, CA 90024, USA
    Hum Gene Ther 13:1245-58. 2002
    ..If more broadly applied, this model could be used to examine the effects of any gene, using any gene delivery system in the three-dimensional context of native tumoral architecture...
  18. ncbi Images in clinical medicine. Pseudomyxoma peritonei
    Sanford H Barsky
    UCLA School of Medicine, Los Angeles, CA 90024, USA
    N Engl J Med 350:e13. 2004
  19. ncbi Atypical ductal hyperplasia presenting as pseudomicrocalcifications
    Henry C H Tsai
    Department of Pathology, UCLA School of Medicine, Los Angeles, California 90024, USA
    Breast J 9:39-40. 2003
    ..Upon excision, these turned out to be pseudomicrocalcifications created by the intraductal cellular proliferations of atypical ductal hyperplasia so dense as to create radiodensities...
  20. ncbi Comparative oncological studies of feline bronchioloalveolar lung carcinoma, its derived cell line and xenograft
    Deborah A Grossman
    Department of Pathology, University of California-Los Angeles School of Medicine, Los Angeles, California 90024, USA
    Cancer Res 62:3826-33. 2002
    ..These studies of feline BAC may allow insights into the human disease that are not possible by studying human BAC directly...
  21. ncbi Clinicopathologic analysis of sentinel lymph node mapping in early breast cancer
    Seung-Hye Choi
    Department of Surgery, Revlon/UCLA Breast Center, UCLA Medical Center, Los Angeles, California 90095, USA
    Breast J 9:153-62. 2003
    ....
  22. ncbi Anatomy of the nipple and breast ducts revisited
    Susan M Love
    Department of General Surgery, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA
    Cancer 101:1947-57. 2004
    ..Increasing interest in the intraductal approach to the breast has necessitated revisiting the anatomy of the breast...
  23. ncbi MUC2 is a molecular marker for pseudomyxoma peritonei
    Jerome T O'Connell
    Department of Pathology, UCLA School of Medicine, Los Angeles, California 90024, USA
    Mod Pathol 15:958-72. 2002
    ..In all cases studied, the fidelity of MUC2 and MUC5AC expression held irrespective of the degree of malignant transformation which was present. MUC2 is therefore a reliable molecular marker for pseudomyxoma peritonei...
  24. ncbi Cooperative role of E-cadherin and sialyl-Lewis X/A-deficient MUC1 in the passive dissemination of tumor emboli in inflammatory breast carcinoma
    Mary L Alpaugh
    Department of Pathology, UCLA School of Medicine, Los Angeles, California, CA 90024, USA
    Oncogene 21:3631-43. 2002
    ..1). Our findings support the cooperative role of E-cadherin and sialyl-Lewis X/A-deficient MUC1 in the passive dissemination of tumor emboli in IBC...
  25. ncbi Identification of a novel endothelial-derived gene EG-1
    Canhui Liu
    Division of Surgical Oncology, UCLA School of Medicine, Los Angeles, CA 90095, USA
    Biochem Biophys Res Commun 290:602-12. 2002
    ..4-kb RNA form. Our data suggest that EG-1 is associated with a stimulated state in endothelial and epithelial cells, and may have a role in tumor angiogenesis...
  26. ncbi Precancerous stem cells can serve as tumor vasculogenic progenitors
    Rulong Shen
    Department of Pathology and Comprehensive Cancer Center, Ohio State University, Columbus, Ohio, USA
    PLoS ONE 3:e1652. 2008
    ..Our studies indicate that pCSCs can serve as tumor vasculogenic stem/progenitor cells (TVPCs), and may explain why anti-angiogenic cancer therapy trials are facing challenge...
  27. ncbi Semi-automated imaging system to quantitate Her-2/neu membrane receptor immunoreactivity in human breast cancer
    Aparna S Joshi
    BioImagene Inc, Suite 212, Cupertino, California 95014, USA
    Cytometry A 71:273-85. 2007
    ..Immunocytochemical methods for quantitating Her-2/neu immunoreactivity rest on subjective semi-quantitative interpretations with resulting interobserver, intraobserver, and fatigue variability...
  28. ncbi Novel interactions of vitamin E and estrogen in breast cancer
    Hilda Chamras
    Division of Hematology Oncology, Department of Medicine, University of California at Los Angeles, School of Medicine 90095 1678, USA
    Nutr Cancer 52:43-8. 2005
    ..This provides evidence that vitamin E may inhibit ER-positive cell growth by altering the cellular response to estrogen...